J. B. Chemicals & Pharmaceuticals Limited (NSE:JBCHEPHARM)

NSE:JBCHEPHARM Statistics

Total Valuation

NSE:JBCHEPHARM has a market cap or net worth of INR 270.46 billion. The enterprise value is 264.92 billion.

Market Cap	270.46B
Enterprise Value	264.92B

Important Dates

The last earnings date was Tuesday, November 11, 2025.

Earnings Date	Nov 11, 2025
Ex-Dividend Date	Jul 30, 2025

Share Statistics

Current Share Class	156.63M
Shares Outstanding	n/a
Shares Change (YoY)	-0.27%
Shares Change (QoQ)	+0.10%
Owned by Insiders (%)	0.13%
Owned by Institutions (%)	30.11%
Float	81.37M

Valuation Ratios

The trailing PE ratio is 37.65 and the forward PE ratio is 30.71.

PE Ratio	37.65
Forward PE	30.71
PS Ratio	6.61
PB Ratio	7.11
P/TBV Ratio	10.93
P/FCF Ratio	34.72
P/OCF Ratio	30.48
PEG Ratio	n/a

Enterprise Valuation

The stock's EV/EBITDA ratio is 24.31, with an EV/FCF ratio of 34.01.

EV / Earnings	36.88
EV / Sales	6.47
EV / EBITDA	24.31
EV / EBIT	28.95
EV / FCF	34.01

Financial Position

The company has a current ratio of 3.79, with a Debt / Equity ratio of 0.01.

Current Ratio	3.79
Quick Ratio	2.27
Debt / Equity	0.01
Debt / EBITDA	0.04
Debt / FCF	0.05
Interest Coverage	169.31

Financial Efficiency

Return on equity (ROE) is 20.47% and return on invested capital (ROIC) is 15.98%.

Return on Equity (ROE)	20.47%
Return on Assets (ROA)	13.09%
Return on Invested Capital (ROIC)	15.98%
Return on Capital Employed (ROCE)	22.66%
Revenue Per Employee	7.71M
Profits Per Employee	1.35M
Employee Count	5,304
Asset Turnover	0.94
Inventory Turnover	2.44

Taxes

In the past 12 months, NSE:JBCHEPHARM has paid 2.43 billion in taxes.

Income Tax	2.43B
Effective Tax Rate	25.31%

Stock Price Statistics

The stock price has increased by +3.75% in the last 52 weeks. The beta is -0.07, so NSE:JBCHEPHARM's price volatility has been lower than the market average.

Beta (5Y)	-0.07
52-Week Price Change	+3.75%
50-Day Moving Average	1,710.83
200-Day Moving Average	1,673.37
Relative Strength Index (RSI)	46.93
Average Volume (20 Days)	219,499

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, NSE:JBCHEPHARM had revenue of INR 40.92 billion and earned 7.18 billion in profits. Earnings per share was 45.29.

Revenue	40.92B
Gross Profit	27.23B
Operating Income	9.15B
Pretax Income	9.62B
Net Income	7.18B
EBITDA	10.78B
EBIT	9.15B
Earnings Per Share (EPS)	45.29

Balance Sheet

The company has 5.94 billion in cash and 409.10 million in debt, giving a net cash position of 5.53 billion.

Cash & Cash Equivalents	5.94B
Total Debt	409.10M
Net Cash	5.53B
Net Cash Per Share	n/a
Equity (Book Value)	38.06B
Book Value Per Share	243.38
Working Capital	18.81B

Cash Flow

In the last 12 months, operating cash flow was 8.87 billion and capital expenditures -1.08 billion, giving a free cash flow of 7.79 billion.

Operating Cash Flow	8.87B
Capital Expenditures	-1.08B
Free Cash Flow	7.79B
FCF Per Share	n/a

Margins

Gross margin is 66.55%, with operating and profit margins of 22.37% and 17.56%.

Gross Margin	66.55%
Operating Margin	22.37%
Pretax Margin	23.51%
Profit Margin	17.56%
EBITDA Margin	26.35%
EBIT Margin	22.37%
FCF Margin	19.04%

Dividends & Yields

This stock pays an annual dividend of 15.50, which amounts to a dividend yield of 0.89%.

Dividend Per Share	15.50
Dividend Yield	0.89%
Dividend Growth (YoY)	26.53%
Years of Dividend Growth	2
Payout Ratio	33.64%
Buyback Yield	0.27%
Shareholder Yield	1.16%
Earnings Yield	2.66%
FCF Yield	2.88%

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value
Lynch Upside
Graham Number
Graham Upside

Stock Splits

The last stock split was on September 18, 2023. It was a forward split with a ratio of 2.

Last Split Date	Sep 18, 2023
Split Type	Forward
Split Ratio	2

Scores

Altman Z-Score	n/a
Piotroski F-Score	6